Aisling Capital Management as of Sept. 30, 2019
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 13 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 42.9 | $82M | 3.8M | 21.47 | |
| Eidos Therapeutics | 21.1 | $40M | 1.1M | 35.97 | |
| Avrobio Ord (AVRO) | 6.6 | $13M | 893k | 14.12 | |
| Obseva Sa | 6.0 | $12M | 1.4M | 8.33 | |
| Marker Therapeutics Ord | 5.3 | $10M | 2.0M | 5.11 | |
| Aeglea Biotherapeutics | 5.2 | $9.9M | 1.3M | 7.69 | |
| Sunesis Pharmaceuticals Inc Ne | 3.8 | $7.3M | 10M | 0.72 | |
| Atreca Inc Cl A (BCEL) | 2.5 | $4.7M | 388k | 12.24 | |
| Nabriva Therapeutics | 2.0 | $3.8M | 1.9M | 2.00 | |
| Zosano Pharma Corp | 1.6 | $3.2M | 2.0M | 1.56 | |
| Arcus Biosciences Incorporated (RCUS) | 1.6 | $3.0M | 333k | 9.10 | |
| Verona Pharma Plc ads (VRNA) | 1.1 | $2.0M | 444k | 4.57 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $685k | 635k | 1.08 |
